Citius Pharmaceuticals (CTXR) Q1 2025 Earnings
CTXR·Reported May 14, 2025·Before market open
Diluted EPS came in at $-1.27 (-1.6% YoY), missed the $-1.08 consensus by $0.19.
Diluted EPS
$-1.27missed by $0.19
Consensus: $-1.08
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Citius Pharmaceuticals's Q1 2025 earnings report.
Citius Pharmaceuticals (CTXR) reported Q1 2025 earnings on May 14, 2025 before market open.
Citius Pharmaceuticals reported diluted EPS of $-1.27 for Q1 2025.
EPS missed the consensus estimate of $-1.08 by $0.19.
Compared to the same quarter a year prior, diluted EPS declined 1.6% from $-1.25.
You can read the 10-Q periodic report (0001213900-25-043360) directly on SEC EDGAR. The filing index links above go to sec.gov.